Form 4: Vaccinex Director Albert Friedberg Reports Significant Share Purchases

Albert Friedberg, a director and 10% owner of Vaccinex, Inc., reports acquiring a substantial number of shares through multiple transactions, along with indirect ownership through related entities.

Summary

• Albert Friedberg, a director and 10% owner of Vaccinex, Inc. (VCNX), filed a Form 4 detailing changes in beneficial ownership.
• The report indicates purchases of common stock on July 31, 2024, through various entities including FCMI Parent Co.
• Mr. Friedberg also indirectly owns shares through Pan Atlantic Holdings Ltd. and Friedberg Global-Macro Hedge Fund Ltd.
• The weighted average prices for the purchases ranged from $5.10 to $7.40 per share.
• FCMI Parent Co. holds warrants to purchase Vaccinex common stock at exercise prices of $7.64 and $14.
• Mr. Friedberg has granted limited power of attorney to Jill Sanchez and Maurice Zauderer for Section 16 reporting obligations.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but it's important to consider the context and the individual's overall holdings. The purchases are not large enough to indicate a strong positive sentiment.

Positives

• The director's purchase of shares could be interpreted as a positive signal about the company's prospects.
• The purchases demonstrate a financial commitment to Vaccinex by a key insider.

Industry Context

This filing is a routine disclosure required by the SEC for insiders who trade in their company's stock. It provides transparency to the market regarding the actions of key individuals.

Stakeholder Impact

• Shareholders may view the insider buying as a positive sign.
• The increased ownership by Friedberg and related entities could influence corporate decisions.

Key Dates

Keywords

Vaccinex, VCNX, Albert Friedberg, Form 4, Beneficial Ownership, Insider Trading, Share Purchases, FCMI Parent Co., Warrants, Director